V

Valence Life Sciences

0 employees

Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing.

Investor insights

Sectors invested in

Health Care2

Pharmaceutical1

Biotechnology1

Health Diagnostics1

Medical1

Biopharma1

Medical Device1

Manufacturing1

Funding rounds participated in

$24M sweet spot round size

Most of their 8 investments are in rounds between $15M and $36M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Angel Investment

Biotech

Life Science

Venture Capital

Date founded

2012

Investments made

U

Undisclosed raised $21M on March 11, 2021

Investors: Sanderling Ventures, Quark Venture and Valence Life Sciences

U

Undisclosed raised $15M on May 22, 2020

Investors: Sanderling Ventures, Bering Capital and Valence Life Sciences

J

JenaValve Technology, Inc. raised $50M on February 5, 2020

Investors: Gimv, VI Partners AG, Legend Capital, Andera Partners and Valence Life Sciences

U

Undisclosed raised $23M on February 13, 2015

Investors: HealthCare Royalty Partners, Kleiner Perkins, Wellington Management, InterWest Partners and Valence Life Sciences

U

Undisclosed raised $36M on March 4, 2014

Investors: HealthCare Royalty Partners, Helix Ventures, Kleiner Perkins, InterWest Partners and Valence Life Sciences

C

Celator Pharmaceuticals raised $39M on April 30, 2013

Investors: ROTH Capital Partners and Valence Life Sciences

U

Undisclosed raised $25M on June 14, 2012

Investors: Wexford Capital LP, InterWest Partners, Kleiner Perkins and Valence Life Sciences

U

Undisclosed raised $2M on January 9, 2012

Investors: Helix Ventures, Kleiner Perkins, Wexford Capital LP, InterWest Partners and Valence Life Sciences